Compare RCKT & RMNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RCKT | RMNI |
|---|---|---|
| Founded | 1999 | 2005 |
| Country | United States | United States |
| Employees | 202 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 534.2M | 338.2M |
| IPO Year | N/A | 2015 |
| Metric | RCKT | RMNI |
|---|---|---|
| Price | $4.87 | $3.26 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 2 |
| Target Price | ★ $29.65 | $5.50 |
| AVG Volume (30 Days) | ★ 2.9M | 413.4K |
| Earning Date | 01-01-0001 | 05-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 197.50 |
| EPS | N/A | ★ 0.39 |
| Revenue | N/A | ★ $431,496,000.00 |
| Revenue This Year | N/A | $6.02 |
| Revenue Next Year | $97.68 | $5.50 |
| P/E Ratio | ★ N/A | $8.44 |
| Revenue Growth | N/A | ★ 5.33 |
| 52 Week Low | $2.19 | $2.87 |
| 52 Week High | $8.80 | $5.38 |
| Indicator | RCKT | RMNI |
|---|---|---|
| Relative Strength Index (RSI) | 58.97 | 39.83 |
| Support Level | $2.99 | $2.92 |
| Resistance Level | $5.34 | $4.14 |
| Average True Range (ATR) | 0.38 | 0.16 |
| MACD | -0.00 | -0.03 |
| Stochastic Oscillator | 51.16 | 1.71 |
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.
Rimini Street Inc and its subsidiaries are providers of end-to-end enterprise software support, products, and services. The company offers a comprehensive family of unified solutions to run, manage, support, customize, configure, connect, protect, monitor, and optimize clients' enterprise applications, databases, and technology software platforms. The company derives revenues from clients by providing subscription support services for enterprise resource planning, customer relationship management, product lifecycle management, database, and technology software systems. Geographically, the company generates its revenue from the United States of America and the International market.